ICD-10 Search Results for comp-following-infusion-transfusion-and-theraputc-injection-t80


ICD-10-CM CodeDescriptionCategoryValid for Submission
T80Complications following infusion, transfusion and therapeutic injectionNot Valid
T80.0XXAAir embolism following infusion, transfusion and therapeutic injection, initial encounter
Air embolism as a complication of medical care; Air embolism as a complication of medical care; Air embolism as a complication of medical care; Air embolism complicating intravenous therapy; Air embolism complicating injection; Air embolism due to and following transfusion; Transfusion reaction due to air embolism; Air embolism due to and following transfusion; Air embolism due to and following transfusion; Air embolism complicating injection;
Valid
T80.0XXDAir embolism following infusion, transfusion and therapeutic injection, subsequent encounter
Air embolism as a complication of medical care; Air embolism as a complication of medical care; Air embolism as a complication of medical care; Air embolism complicating intravenous therapy; Air embolism complicating injection; Air embolism due to and following transfusion; Transfusion reaction due to air embolism; Air embolism due to and following transfusion; Air embolism due to and following transfusion; Air embolism complicating injection;
Valid
T80.0XXSAir embolism following infusion, transfusion and therapeutic injection, sequela
Air embolism as a complication of medical care; Air embolism as a complication of medical care; Air embolism as a complication of medical care; Air embolism complicating intravenous therapy; Air embolism complicating injection; Air embolism due to and following transfusion; Transfusion reaction due to air embolism; Air embolism due to and following transfusion; Air embolism due to and following transfusion; Air embolism complicating injection;
Valid
T80.1Vascular complications following infusion, transfusion and therapeutic injectionNot Valid
T80.1XXAVascular complications following infusion, transfusion and therapeutic injection, initial encounter
Superficial thrombophlebitis following administration of drug via intravenous route; Necrosis following injection of local anesthetic; Phlebitis following perfusion; Phlebitis following transfusion; Thrombophlebitis following perfusion; Thrombophlebitis following transfusion; Phlebitis after infusion; Thromboembolism after infusion; Thrombophlebitis after infusion; Phlebitis following transfusion; Thrombophlebitis following transfusion; Necrosis following injection of local anesthetic;
Valid
T80.1XXDVascular complications following infusion, transfusion and therapeutic injection, subsequent encounter
Superficial thrombophlebitis following administration of drug via intravenous route; Necrosis following injection of local anesthetic; Phlebitis following perfusion; Phlebitis following transfusion; Thrombophlebitis following perfusion; Thrombophlebitis following transfusion; Phlebitis after infusion; Thromboembolism after infusion; Thrombophlebitis after infusion; Phlebitis following transfusion; Thrombophlebitis following transfusion; Necrosis following injection of local anesthetic;
Valid
T80.1XXSVascular complications following infusion, transfusion and therapeutic injection, sequela
Superficial thrombophlebitis following administration of drug via intravenous route; Necrosis following injection of local anesthetic; Phlebitis following perfusion; Phlebitis following transfusion; Thrombophlebitis following perfusion; Thrombophlebitis following transfusion; Phlebitis after infusion; Thromboembolism after infusion; Thrombophlebitis after infusion; Phlebitis following transfusion; Thrombophlebitis following transfusion; Necrosis following injection of local anesthetic;
Valid
T80.8Other complications following infusion, transfusion and therapeutic injectionNot Valid
T80.89Other complications following infusion, transfusion and therapeutic injectionNot Valid
T80.89XAOther complications following infusion, transfusion and therapeutic injection, initial encounter
Sclerosing peritonitis as complication of peritoneal dialysis; Hydrothorax as complication of peritoneal dialysis; Abdominal hernia as complication of peritoneal dialysis; Hemoperitoneum as complication of peritoneal dialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Adverse reaction following injection of substance; Extravasation due to and following blood transfusion; Thromboembolism following infusion, perfusion AND/OR transfusion; Polycythemia neonatorum following blood transfusion; Neonatal hyperbilirubinemia following total parenteral nutrition; Osteonecrosis due to and following renal dialysis; Injury due to and following infusion; Injury due to and following transfusion; Injury due to and following therapeutic injection; Mechanical failure of instrument or apparatus during infusion or transfusion; Air in infusion or transfusion due to mechanical failure of apparatus; Thromboembolism following infusion, perfusion AND/OR transfusion; Injury due to and following infusion; Infusion site swelling; Alloimmune platelet transfusion refractoriness; Mechanical failure of instrument or apparatus during infusion or transfusion; Pulmonary transfusion reaction; Air in infusion or transfusion due to mechanical failure of apparatus; Erythrocytosis due to autotransfusion; Urticarial transfusion reaction; Transfusion reaction due to products of cell metabolism; Extravasation due to and following blood transfusion; Allergic transfusion reaction; Hemolytic transfusion reaction; Thromboembolism following infusion, perfusion AND/OR transfusion; Transfusion reaction due to toxic effect of anticoagulant; Transfusion hemosiderosis; Transfusion reaction due to toxic substance in blood; Polycythemia neonatorum following blood transfusion; Injury due to and following transfusion; Extravasation due to and following blood transfusion; Thromboembolism following infusion, perfusion AND/OR transfusion; Chronic kidney disease mineral and bone disorder; Osteonecrosis due to and following renal dialysis; Injury due to and following infusion; Injury due to and following transfusion; Injury due to and following therapeutic injection; Adverse reaction following injection of substance; Myelopathy post intrathecal injection of chemotherapeutic agent; Erythema at injection site; Swelling at injection site; Injection neuropathy; Injury due to and following therapeutic injection; Injection site itching; Injection site cellulitis; Injection site indentation; Blister at injection site; Injection site eruption; Injection site eruption; Injection site pruritus; Injection site hypersensitivity; Injection site irritation; Injection site pigmentation change; Injection site hemorrhage; Injection site thrombosis; Injection site malabsorption; Injection site pain; Injection site burning; Injection site nerve damage; Injection site inflammation; Injection site inflammation; Injection site inflammation; Injection site edema; Injection site edema; Injection site dermatitis; Injection site urticaria; Injection site mass; Injection site mass; Injection site cyst; Injection site necrosis; Injection site anesthesia; Injection site paresthesia; Injection site bruising; Injection site induration; Injection site fibrosis; Injection site atrophy;
Valid
T80.89XDOther complications following infusion, transfusion and therapeutic injection, subsequent encounter
Sclerosing peritonitis as complication of peritoneal dialysis; Hydrothorax as complication of peritoneal dialysis; Abdominal hernia as complication of peritoneal dialysis; Hemoperitoneum as complication of peritoneal dialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Adverse reaction following injection of substance; Extravasation due to and following blood transfusion; Thromboembolism following infusion, perfusion AND/OR transfusion; Polycythemia neonatorum following blood transfusion; Neonatal hyperbilirubinemia following total parenteral nutrition; Osteonecrosis due to and following renal dialysis; Injury due to and following infusion; Injury due to and following transfusion; Injury due to and following therapeutic injection; Mechanical failure of instrument or apparatus during infusion or transfusion; Air in infusion or transfusion due to mechanical failure of apparatus; Thromboembolism following infusion, perfusion AND/OR transfusion; Injury due to and following infusion; Infusion site swelling; Alloimmune platelet transfusion refractoriness; Mechanical failure of instrument or apparatus during infusion or transfusion; Pulmonary transfusion reaction; Air in infusion or transfusion due to mechanical failure of apparatus; Erythrocytosis due to autotransfusion; Urticarial transfusion reaction; Transfusion reaction due to products of cell metabolism; Extravasation due to and following blood transfusion; Allergic transfusion reaction; Hemolytic transfusion reaction; Thromboembolism following infusion, perfusion AND/OR transfusion; Transfusion reaction due to toxic effect of anticoagulant; Transfusion hemosiderosis; Transfusion reaction due to toxic substance in blood; Polycythemia neonatorum following blood transfusion; Injury due to and following transfusion; Extravasation due to and following blood transfusion; Thromboembolism following infusion, perfusion AND/OR transfusion; Chronic kidney disease mineral and bone disorder; Osteonecrosis due to and following renal dialysis; Injury due to and following infusion; Injury due to and following transfusion; Injury due to and following therapeutic injection; Adverse reaction following injection of substance; Myelopathy post intrathecal injection of chemotherapeutic agent; Erythema at injection site; Swelling at injection site; Injection neuropathy; Injury due to and following therapeutic injection; Injection site itching; Injection site cellulitis; Injection site indentation; Blister at injection site; Injection site eruption; Injection site eruption; Injection site pruritus; Injection site hypersensitivity; Injection site irritation; Injection site pigmentation change; Injection site hemorrhage; Injection site thrombosis; Injection site malabsorption; Injection site pain; Injection site burning; Injection site nerve damage; Injection site inflammation; Injection site inflammation; Injection site inflammation; Injection site edema; Injection site edema; Injection site dermatitis; Injection site urticaria; Injection site mass; Injection site mass; Injection site cyst; Injection site necrosis; Injection site anesthesia; Injection site paresthesia; Injection site bruising; Injection site induration; Injection site fibrosis; Injection site atrophy;
Valid
T80.89XSOther complications following infusion, transfusion and therapeutic injection, sequela
Sclerosing peritonitis as complication of peritoneal dialysis; Hydrothorax as complication of peritoneal dialysis; Abdominal hernia as complication of peritoneal dialysis; Hemoperitoneum as complication of peritoneal dialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Adverse reaction following injection of substance; Extravasation due to and following blood transfusion; Thromboembolism following infusion, perfusion AND/OR transfusion; Polycythemia neonatorum following blood transfusion; Neonatal hyperbilirubinemia following total parenteral nutrition; Osteonecrosis due to and following renal dialysis; Injury due to and following infusion; Injury due to and following transfusion; Injury due to and following therapeutic injection; Mechanical failure of instrument or apparatus during infusion or transfusion; Air in infusion or transfusion due to mechanical failure of apparatus; Thromboembolism following infusion, perfusion AND/OR transfusion; Injury due to and following infusion; Infusion site swelling; Alloimmune platelet transfusion refractoriness; Mechanical failure of instrument or apparatus during infusion or transfusion; Pulmonary transfusion reaction; Air in infusion or transfusion due to mechanical failure of apparatus; Erythrocytosis due to autotransfusion; Urticarial transfusion reaction; Transfusion reaction due to products of cell metabolism; Extravasation due to and following blood transfusion; Allergic transfusion reaction; Hemolytic transfusion reaction; Thromboembolism following infusion, perfusion AND/OR transfusion; Transfusion reaction due to toxic effect of anticoagulant; Transfusion hemosiderosis; Transfusion reaction due to toxic substance in blood; Polycythemia neonatorum following blood transfusion; Injury due to and following transfusion; Extravasation due to and following blood transfusion; Thromboembolism following infusion, perfusion AND/OR transfusion; Chronic kidney disease mineral and bone disorder; Osteonecrosis due to and following renal dialysis; Injury due to and following infusion; Injury due to and following transfusion; Injury due to and following therapeutic injection; Adverse reaction following injection of substance; Myelopathy post intrathecal injection of chemotherapeutic agent; Erythema at injection site; Swelling at injection site; Injection neuropathy; Injury due to and following therapeutic injection; Injection site itching; Injection site cellulitis; Injection site indentation; Blister at injection site; Injection site eruption; Injection site eruption; Injection site pruritus; Injection site hypersensitivity; Injection site irritation; Injection site pigmentation change; Injection site hemorrhage; Injection site thrombosis; Injection site malabsorption; Injection site pain; Injection site burning; Injection site nerve damage; Injection site inflammation; Injection site inflammation; Injection site inflammation; Injection site edema; Injection site edema; Injection site dermatitis; Injection site urticaria; Injection site mass; Injection site mass; Injection site cyst; Injection site necrosis; Injection site anesthesia; Injection site paresthesia; Injection site bruising; Injection site induration; Injection site fibrosis; Injection site atrophy;
Valid
T80.9Unspecified complication following infusion, transfusion and therapeutic injectionNot Valid